#liver-disease
After early Semaglutide lead, Torrent Pharma eyes US liver drug Resmetirom for India launch
Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic health
Liver Disease Diagnostics Market Insights Report 2026-2032 | Expansion of Fibrosis and Cirrhosis Screening Programs Propels Use of Imaging and Blood-Based Diagnostic Platforms
The market presents opportunities driven by rising liver disease prevalence, demand for non-invasive and AI diagnostics, and personalized medicine trends The market presents opportunities driven by rising liver disease prevalence, demand for non-invasive and …